Sensory Feedback Intervention for Speech Motor Learning
Trial Summary
What is the purpose of this trial?
These studies test the hypothesis that sensory areas of the brain participate in the consolidation of speech motor memory by using transcranial magnetic stimulation to suppress activity in somatosensory and auditory cortex following adaptation in order to block retention of learning.
Will I have to stop taking my current medications?
If you are currently taking antipsychotic, antidepressant, or antianxiety drugs, you would not be eligible to participate in this trial.
What data supports the effectiveness of the treatment Adaptation, cTBS, Continuous Theta-Burst Stimulation, cTBS, Theta-Burst Transcranial Magnetic Stimulation for speech motor learning?
Research shows that real-time sensory feedback, especially auditory feedback, is crucial for speech motor learning. Studies indicate that altering auditory feedback can lead to adaptation in speech production, suggesting that treatments focusing on sensory feedback, like the one in the trial, may help improve speech motor learning.12345
Is the sensory feedback intervention for speech motor learning safe for humans?
The research articles provided do not contain specific safety data for the sensory feedback intervention or related techniques like cTBS or Theta-Burst Transcranial Magnetic Stimulation. They focus on the mechanisms and effects of speech motor learning and feedback processing without addressing safety concerns.26789
How does the Adaptation treatment for speech motor learning differ from other treatments?
The Adaptation treatment for speech motor learning is unique because it involves altering both auditory and somatosensory feedback in real-time to help individuals adjust their speech movements. This approach focuses on the integration of sensory feedback to correct speech production, which is different from other treatments that may not simultaneously address both auditory and somatosensory inputs.2561011
Research Team
David Ostry
Principal Investigator
Haskins Laboratories
Eligibility Criteria
This trial is for right-handed adults with no known physical or neurological abnormalities. It's not suitable for those with epilepsy, a family history of it, on antidepressants/antipsychotics/antianxiety drugs, with heart devices/metal in the body, who are pregnant, or have had concussions.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Adaptation and Stimulation
Subjects train using altered sensory feedback followed by cTBS to test motor memory consolidation
Retention Assessment
Subjects return to assess retention of learning 24 hours after initial adaptation and stimulation
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Adaptation
- cTBS
Find a Clinic Near You
Who Is Running the Clinical Trial?
Yale University
Lead Sponsor
McGill University
Collaborator
National Institute on Deafness and Other Communication Disorders (NIDCD)
Collaborator